Preclinical development

#Assays #iPSC #Neuroscience #Preclinical development

10 practical tips for reliable MEA experiments in preclinical neuroscience

Combining human iPSC-derived neurons with multi-electrode array (MEA) assays can provide powerful insights into synaptic connectivity, network dynamics, and functional maturation. However, MEA experiments can be challenging, with small changes in cell culture conditions dramatically impacting results. In this expert Guide, bit.bio’s Field Applications Scientist shares key considerations for improving… Read More

#Resources

#Centauri Therapeutics #Gram-negative bacteria #Immunotherapy #Preclinical development

Bifunctional immunotherapy active against Gram-negative infections

A new paper has presented the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infections. The study in The Journal of Immunology presents proof-of-concept data for CTX-09, an early molecule built on Centauri Therapeutics’ Alphamer platform.   In… Read More

#News

Covid-19
#Covid-19 #Immunology / Virology & Vaccines #Preclinical development #Rocketvax #SARS-CoV-2

Robust preclinical results for live-attenuated SARS-CoV-2 vaccine

Live-attenuated SARS-CoV-2 vaccine candidate, OTS-228, has demonstrated exceptional safety, efficacy, and genomic stability in preclinical animal models.  The vaccine was developed under the scientific leadership of Professor Dr Volker Thiel, Chief Scientist of Rocketvax and Professor of Virology at the University of Bern.  The latest… Read More

#News #Trending News

E coli bacteria
#Antivirulence #Bacteria #Gut microbiome #Mouse models #Preclinical development #University of Glasgow

Early studies identify a new treatment for E coli infections

Scientists have taken an important step toward the development of a potential new treatment for treating Shiga toxin-producing E coli (STEC), the bacteria associated with severe food poisoning.  The findings – led by the University of Glasgow and published in Antimicrobials and… Read More

#News

Humanised mouse models
#Animal models #Humanised Immune System (HIS) #Mouse models #Preclinical development #Whitepaper

Whitepaper: Introduction to humanised immune system mice

A new Whitepaper from Taconic Biosciences is now available to download entitled ‘An Introduction to Humanized Immune System Mouse Models‘. Traditional mouse models have limitations in recapitulating human biology — but humanised immune system (HIS) mice offer a more predictive approach. These advanced models bring you closer to clinical… Read More

#News

#Animal models #Humanised Immune System (HIS) #Mouse models #Preclinical development

Introduction to humanised immune system mice

Unlock the power of humanised immune system mice. Traditional mouse models have limitations in recapitulating human biology — but humanised immune system (HIS) mice offer a more predictive approach. These advanced models bring you closer to clinical relevance. Download this Whitepaper to discover: The evolution of immunodeficient mice Key humanisation… Read More

#Resources

The microbiome
#Gut microbiome #Microbiome #Microbiotica #Preclinical development #Ulcerative colitis (UC)

Preclinical data reveals mechanism behind microbiome therapy

Microbiotica has revealed new data on the mechanism of action of MB310, its product in development as a treatment for ulcerative colitis (UC).   The data were shared at the Keystone Symposia ‘Human Microbiome: Diversity, Selection and Adaptation’ held 18-21 February in Banff, Canada and at the European… Read More

#News

#Genetics / genomics #Mouse models #Preclinical development #Preclinical investigations #Webinar

Watch now: Ensure genetic integrity in rodent models

A new on-demand webinar is now available from Taconic Biosciences. Join geneticist Bart Smits PhD as he outlines key considerations for designing and maintaining a robust mouse colony to support your preclinical research needs. Dr Bart Smits currently leads the Department of Genetic Sciences and Compliance at Taconic… Read More

Webinar date:
Brought to you by Taconic Biosciences
#News

#Genetics / genomics #Mouse models #Preclinical development #Preclinical investigations

Safeguarding Genetic Integrity in Preclinical Rodent Models

Join geneticist Bart Smits, PhD in this exclusive webinar as he outlines key considerations for designing and maintaining a robust mouse colony to support your preclinical research needs. Secure your spot to: Understand the impact of background strain and substrain on mutation expression. Explore effective… Read More

Webinar date:
Brought to you by Taconic Biosciences
#Webinars

#Humanised Immune System (HIS) #In vivo #Mouse models #Preclinical development #Whitepaper

Whitepaper: Unlock drug discovery with HIS mouse models

Sophisticated in vivo models are paramount for evolving drug research and developing biologic therapeutics. A new whitepaper from Taconic Biosciences delves into the challenges faced by researchers in sourcing appropriate models and how humanized immune system (HIS) models can provide innovative solutions. You will learn about: The significance of… Read More

#News

#Humanised Immune System (HIS) #In vivo #Mouse models #Preclinical development

Unlocking drug discovery with humanized immune system mouse models

Sophisticated in vivo models are paramount for evolving drug research and developing biologic therapeutics. Our whitepaper delves into the challenges faced by researchers in sourcing appropriate models and how humanized immune system (HIS) models can provide innovative solutions. You will learn about: The significance of HIS models in bridging the… Read More

#Resources

Ovarian cancer cells
#Oncology #Panavance Therapeutics #PARP inhibitors #Preclinical development

New data support antitumour drug misetionamide in ovarian cancers

New published data have demonstrated positive monotherapy results for misetionamide as well as synergistic activity with PARP inhibitors (PARPis) and bevacizumab antineoplastic in ovarian cancer. Misetionamide is a tumour cell selective small molecule drug that is broadly active in multiple cancer models. Misetionamide’s inhibition… Read More

#Cancer Research #News

A laboratory mouse
#Clinical trials #Drug toxicity #In vivo #Mouse models #Preclinical development #Whitepaper

How can you ensure a confident transition to human trials?

A new whitepaper is now available from The Jackson Laboratory, entitled ‘Evidence-based selection of the starting dose in first-in-human clinical trials using humanised mouse models‘. This paper discusses the challenges drug developers face when transitioning from preclinical discovery to clinical trials and proposes expanding the drug development… Read More

#News

#Clinical trials #Drug toxicity #In vivo #Mouse models #Preclinical development

The in vivo tool enabling a confident transition to Phase I trials

This paper discusses the challenges drug developers face when transitioning from preclinical discovery to clinical trials and proposes expanding the drug development toolbox with humanised mouse models. Download the latest whitepaper to learn more about: The importance of selecting appropriate starting doses in clinical trials. Why humanised mice better predict… Read More

#Resources

Child with cystic fibrosis on ventilator
#Animal models #Cystic fibrosis #Enterprise Therapeutics #Preclinical development

ENaC blocker enhances mucus clearance in cystic fibrosis models

A preclinical study in cystic fibrosis sheep models has demonstrated that low doses of the ENaC blocker ETD001 can enhance airway mucus clearance with a long duration of action. The study indicates that ETD001, at a dose level that was well tolerated in healthy volunteers, provides… Read More

#News

Bone marrow organoids
#Drug discovery #Human disease models #Organoids #Preclinical development #Webinar

Are organoids superior to other preclinical models?

Developing new drugs is a complex and often lengthy process. A major roadblock lies in the limitations of traditional preclinical models, which often fail to accurately represent the intricate biology of human patients. Join DDW for a free event on 18 June, 3PM… Read More

Webinar date:
Supported by HUB Organoids
#News